Encyclopedia  /  Treatments  /  Zuranolone (Zurzuvae)
Treatment

Zuranolone (Zurzuvae)

Zuranolone (Zurzuvae) is the first oral pill FDA-approved specifically for postpartum depression (August 2023). Taken once daily for just 14 days, it can produce rapid improvement—sometimes within days—making fast-acting PPD treatment far more accessible than the earlier IV option.
Educational information, not medical advice. This page summarizes published research and public-health guidance for learning purposes. It is not a substitute for diagnosis or treatment by a qualified clinician. If you are struggling, talk to your doctor or midwife. In a crisis, call or text 988 or the Maternal Mental Health Hotline at 1-833-852-6262.

Evidence snapshot — computed from live data

125
Studies indexed (PubMed)
2+
Active trials
moderate evidence
Strength score 59/100

A 14-day course

Zuranolone is a neuroactive steroid taken as a two-week course, not indefinitely. In trials it improved depressive symptoms quickly, often by day 3, with benefits observed through follow-up.

Practical considerations

It causes drowsiness, so it’s taken in the evening with fat-containing food, and driving is restricted. Breastfeeding decisions are individualized with a clinician. It represents a genuine breakthrough in how quickly PPD can be treated.

See how this fits alongside other options in our treatment overview, and the medications used for PPD in the medication guide.

Sources & further reading

Selected recent peer-reviewed studies, pulled live from the U.S. National Library of Medicine (PubMed). Counts and citations update automatically.

  1. Dargan TL et al. “Potential of Neurosteroids for Precision Medicine in Psychiatry.” Biological psychiatry (2026). PubMed →
  2. Xie G et al. “Real-world adverse event profiles of Zuranolone and Brexanolone based on FAERS and VigiAccess databases: An observational study.” Medicine (2026). PubMed →
  3. Sheffler ZM et al. “Antidepressants.” (2026). PubMed →
  4. Xiao Y et al. “Comparative efficacy and acceptability of pharmacological interventions for postpartum depression: a systematic review and network meta-analysis.” Psychiatry research (2026). PubMed →
  5. Ok HI et al. “First Reported Case of Dissociative Symptoms Associated With Zuranolone Use in Peripartum Depression.” Cureus (2026). PubMed →
Explore the encyclopedia

Related entries

Common questions

Frequently asked

How is zuranolone different from brexanolone?

Both are neuroactive steroids, but zuranolone is an oral pill taken for 14 days at home, while brexanolone is a 60-hour IV infusion at a certified center.

How quickly does zuranolone work?

In clinical trials, improvement was often seen within about three days—much faster than traditional antidepressants.

Emily Montague, The Postpartum Chef
Written & reviewed by

Emily Montague, The Postpartum Chef

Emily is a chef, mother of five and postpartum-recovery educator who revives the 2,000-year-old zuo yuezi ("sitting month") tradition for modern mothers. Her patent-backed, food-first method helps women rebuild after birth and ease postpartum depression — and she now certifies doulas and midwives to cook it for their own clients.

Visit The Sitting Month →    Meet Emily →

Ready to heal the first 28 days?

Emily's food-first recovery course, recovery teas and doula & midwife certification live at The Sitting Month. Text Emily and she'll help you find the right starting point.

Explore The Sitting Month